EGLN3 Antikörper (Internal Region)
Kurzübersicht für EGLN3 Antikörper (Internal Region) (ABIN4889115)
Target
Alle EGLN3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Internal Region
-
Spezifität
- Reacts with EGLN3 from human, mouse and rat
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide of derived from internal part of human EGLN3.
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC1:100 - 1:1000 WB1:200 - 1:2000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
-
Andere Bezeichnung
- EGLN3
-
Hintergrund
- Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF2A. Hydroxylation on the NODD site by EGLN3 appears to require prior hydroxylation on the CODD site.
-
Gen-ID
- 112399
-
UniProt
- Q9H6Z9
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-